Fundraising Fox

Longevity Investors & VC Firms in Global

80 firms in this list, with a median first check of $500K. 16 of them lead rounds. Generated from verified public data and updated continuously.

OrbiMed
New YorkPre-Seed–Late Stage$1M – $75M
126 people
Sofinnova Partners
ParisPre-Seed–Late Stage$540K – $27M
89 people
Portfolia
San MateoSeed–Late Stage
58 people
SV Health Investors
BostonPre-Seed–Late Stage$1M – $20M
29 people
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
28 people
Draper Associates
San MateoPre-Seed–Series A$500K – $5M
21 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
41 people
BoxOne Ventures
MontréalPre-Seed–Series A$500K
10 people
Social Starts
San FranciscoPre-Seed–Series A
5 people
Illumina Ventures
Foster CityPre-Seed–Late Stage
40 people
LIFTT
TorinoPre-Seed–Late Stage
35 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
42 people
iSelect Fund
St. LouisSeed–Late Stage$250K – $2M
13 people
MPM BioImpact
BostonPre-Seed–Series C$1M – $15M
40 people
Type One Ventures
Los AngelesPre-Seed–Late Stage$100K – $5M
21 people
LongeVC
Washington D.C.Pre-Seed–Series A
39 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
Unruly Capital
LondonPre-Seed–Series A
3 people
StartUp Health
New YorkSeed
42 people
Everywhere Ventures
New YorkPre-Seed–Seed$250K
7 people
DOMiNO Ventures
AmsterdamSeed–Series B$220K – $1.1M
30 people
HealthCap
StockholmSeed–Growth
30 people
ClavystBio
SingaporeSeed–Series A
33 people
aMoon
Ra'ananaSeed–Late Stage
25 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.